Aging involves the progressive accumulation of cellular damage, and one underappreciated form of damage is the buildup of circular RNAs (circRNAs)—unusual RNA molecules that form loops and can interfere with normal cellular function. While researchers knew that circRNAs accumulate during aging, they didn't understand whether this accumulation *causes* aging or what might prevent it. This paper addresses that gap by identifying the enzyme responsible for clearing circRNAs.
The research team conducted a genetic screen in C. elegans (a standard longevity model organism) targeting ribonucleases—enzymes that degrade RNA. They identified RNASEK as uniquely capable of cleaving circRNAs. Crucially, they found that RNASEK levels decline with age, which explains why circRNAs accumulate. To test causation, they either increased RNASEK or removed it in worms and measured lifespan and healthspan (functional aging markers). Boosting RNASEK extended lifespan; removing it shortened it. They then demonstrated the same circRNA-degrading function in mammalian cells and mice, showing the mechanism is evolutionarily conserved.
A mechanistic insight adds depth: the team showed that circRNAs concentrate in "stress granules"—temporary cellular storage bodies that form under stress—where they can aggregate toxically. RNASEK works with the chaperone protein HSP90 to prevent these aggregates, suggesting a protein-folding dimension to circRNA toxicity. This explains *where* circRNA damage occurs and *how* RNASEK prevents it.
Limitations are notable. First, this is a *newly published* finding with zero citations; replication by independent groups is still pending, which is critical for longevity claims. Second, most experiments used C. elegans, an invertebrate with simpler biology than humans; mouse data are mentioned but not detailed in the abstract. Third, the paper doesn't establish whether circRNA accumulation is a *primary* driver of aging or a secondary consequence, though the lifespan data suggest causal relevance. Fourth, no human trials exist—the human cell data are in cultured cells, not living people. Finally, translating this into a therapeutic requires identifying drugs that boost RNASEK or mimic its activity, which hasn't been demonstrated.
This work is significant because it identifies a conserved molecular mechanism linking circRNA clearance to lifespan control, opening a new target for geroprotectors. However, longevity researchers will rightly demand replication before major claims solidify. The finding is most immediately useful as a foundation for *mechanistic* understanding rather than clinical application.
For the general audience: this study proposes that one reason we age is that our cells lose the ability to clean up a type of toxic RNA, and restoring that cleanup machinery extends lifespan in animals. It's a concrete, testable hypothesis—but it's preliminary and unproven in humans.
0 Comments
Log in to join the discussion.